Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP09004 PK/PD Study in Parkinson's
NCT00918177Phase 2Completed
- Sponsor
- Intec Pharma Ltd.
- Start
- Jul 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Intec Pharma Ltd.. Started Jul 2009; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00918177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918177.